Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® > U.S. Anti-obesity Prescription Markets
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

U.S. Anti-obesity Prescription Markets

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2006³â 09¿ù »óǰÄÚµå 45311
ÆäÀÌÁö Á¤º¸ 115 Pages
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This research service covers the Anti-obesity Prescription Markets across the United States for the perios 2002 through 2012.

The research service provides a detailed analysis of the revenue structure across therapies. Strategic recommendations for these have also been discussed along with revenue forecasts.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Introduction

2. INTRODUCTION TO U.S. ANTI-OBESITY PRESCRIPTION MARKETS

Introduction

  • 1. Market Overview
  • 2. Research Scope and Methodology

Basic Obesity Terminologies and Definitions

  • 1. Obesity Definition
  • 2. Obesity Classification
  • 3. Obesity Etiology
  • 4. Obesity Diagnosis

Market Dynamics

  • 1. Analysis
  • 2. Market Drivers
  • 3. Market Restraints
  • 4. Market Trends

Industry Challenges and Strategic Recommendations

  • 1. Industry Challenges
  • 2. Strategic Recommendations

Frost & Sullivan Awards

  • 1. Industry Innovation and Advancement of the Year
  • 2. Technology Innovation of the Year Award
  • 3. Product Differentiation Innovation of the Year Award

3. MARKET SEGMENTATION

Disease and Treatment Overview

  • 1. Obesity Prevalence Forecasts
  • 2. Obesity Diagnosed and Treated Patient Forecasts
  • 3. Obesity Patient Compliance
  • 4. Obesity Comorbid Conditions
  • 5. Unmet Needs in Obesity

Product Analysis

  • 1. Overview of Marketed Products
  • 2. Xenical and Meridia SWOT Analyses
  • 3. Key Patent Expirations

Competitive and Pipeline Analysis

  • 1. Competitive Landscape
  • 2. Competitor Profiles
  • 3. Pipeline Analysis
  • 4. Anticipated Launch Dates
  • 5. Alliances Acquisitions and Licensing Agreements

Market Forecasts

  • 1. Revenue Forecasts and Assumptions
  • 2. Pricing Trends
  • 3. Market Share Analysis

4. APPENDIX

Decision Support Databases

  • 1. Total Population
  • 2. Prevalence of Diabetes Mellitus
  • 3. Diabetes Incidence
  • 4. Prevalence of Obesity
  • 5. Mortality Due to Coronary Heart Disease
Back to Top